Endocrine effects of combined somatostatin analog and bromocriptine therapy in women with advanced breast cancer

[1]  E. Reiter,et al.  Growth hormone , 1993 .

[2]  B. Vonderhaar,et al.  Role of serum in the prolactin responsiveness of MCF-7 human breast cancer cells in long-term tissue culture. , 1987, Cancer research.

[3]  J. Foekens,et al.  Direct inhibitory effects of somatostatin (analogues) on the growth of human breast cancer cells. , 1987, Cancer research.

[4]  K. Alberti,et al.  Effects of SMS 201-995 on intermediary metabolism and endocrine status in normal and diabetic humans. , 1986, The American journal of medicine.

[5]  I. Jackson,et al.  Treatment of resistant acromegaly with a long-acting somatostatin analogue (SMS 201-995). , 1986, Annals of internal medicine.

[6]  J. Hammond,et al.  Prolonged secretion of prolactin in response to thyrotrophin-releasing hormone after hypothalamo-pituitary disconnection in the ewe. , 1986, The Journal of endocrinology.

[7]  D. Cook,et al.  EFFECTS OF SOMATOSTATIN ANALOGUE SMS 201–995 IN NORMAL MAN , 1986, Clinical endocrinology.

[8]  A. Manni,et al.  Promotion by prolactin of the growth of human breast neoplasms cultured in vitro in the soft agar clonogenic assay. , 1986, Cancer research.

[9]  P. Clarenbach,et al.  Endocrine profile of a long-acting somatostatin derivative SMS 201-995. Study in normal volunteers following subcutaneous administration. , 1986, Acta endocrinologica.

[10]  S. Lamberts,et al.  The somatostatin analog SMS 201-995 induces long-acting inhibition of growth hormone secretion without rebound hypersecretion in acromegalic patients. , 1985, The Journal of clinical endocrinology and metabolism.

[11]  S. Bloom,et al.  Long term treatment of acromegaly with a long acting analogue of somatostatin. , 1985, British medical journal.

[12]  A. Schally,et al.  Stimulation by somatostatin of dephosphorylation of membrane proteins in pancreatic cancer MIA PaCa‐2 cell line , 1985, FEBS letters.

[13]  W. Malarkey,et al.  Physiological concentrations of prolactin can promote the growth of human breast tumor cells in culture. , 1983, The Journal of clinical endocrinology and metabolism.

[14]  D. Clemmons,et al.  CHANGES IN CIRCULATING SOMATOMEDIN‐C LEVELS IN BROMOCRIPTINE‐TREATED ACROMEGALY , 1982, Clinical endocrinology.

[15]  R. Mascardo,et al.  Somatostatin inhibits rapid centrosomal separation and cell proliferation induced by epidermal growth factor. , 1982, Endocrinology.

[16]  P. Marbach,et al.  SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action. , 1982, Life sciences.

[17]  R. Santen,et al.  A model for validation of radioimmunoassay kit reagents: measurement of follitropin and lutropin in blood and urine. , 1981, Clinical chemistry.

[18]  R. Santen,et al.  A randomized trial comparing surgical adrenalectomy with aminoglutethimide plus hydrocortisone in women with advanced breast cancer. , 1981, The New England journal of medicine.

[19]  H. Nagasawa.  Prolactin and human breast cancer: a review. , 1979, European journal of cancer.

[20]  A. Manni,et al.  Role of pituitary hormones in the growth of human breast cancer. , 1978, Cancer research.

[21]  H. Friesen,et al.  Hormone binding by human mammary carcinoma. , 1977, Cancer research.

[22]  A. F. Krieg,et al.  A new combined thyroid hormone index based on thyroxine, triiodothyronine and resin uptake. , 1976, American journal of clinical pathology.

[23]  M. Aubert,et al.  Report of the National Pituitary Agency. Collaborative study of the radioimmunoassay of human prolactin. , 1974, The Journal of clinical endocrinology and metabolism.

[24]  C. H. Mortimer,et al.  Growth Hormone Release Inhibiting Hormone in Acromegaly , 1974, British medical journal.

[25]  G. Niswender,et al.  Radioimmunoassay of steroids. , 1970, Acta endocrinologica. Supplementum.

[26]  Marclippman.  The Effects of Estrogens and Antiestrogens on Hormone responsive Human Breast Cancer in Long-Term Tissue Culture , 2006 .

[27]  A. Barkan,et al.  Treatment of acromegaly with the long-acting somatostatin analog SMS 201-995. , 1988, The Journal of clinical endocrinology and metabolism.

[28]  A. Manni,et al.  Hormonal control of breast cancer growth in women and rats. , 1978, Current topics in experimental endocrinology.

[29]  L. Demers,et al.  Comparison of competitive protein binding analysis and radioimmunoassay for the determination of cortisol in serum and urine. , 1977, Clinical biochemistry.